NEU is materially undervalued, page-86

First 86 Last

Share
Profile

Follow
baldwidx

1,365 Posts.

570

23/12/24

14:19

Post #: 77165149
Share

Originally posted by flipper72: ↑

I believe new, potential indications for Phase 2 trials will be announced post the FDA meeting. I expect trial design to be a key discussion point, both Phase 2 & 3.
What I'd like to see, but I doubt will occur, is Neuren announcing in vitro results for Dementia and Parkinsons. I know we won't be completing Phase 2 trials for these two (we would need $billions), but that's not a concern for me. What I'd like us to do is remind the market, shareholders and any prospective big pharma of the positive results seen in mice in studies of 2591 conducted around 2006. I'm sure there are many here who don't know of this. If we can prove it in vitro as well as in mice, surely that would have the smart minds thinking of future opportunities?
Again, I doubt this will happen, but if it was my business and my money and I was looking for catalysts for prospective purchasers, then I'd be going down that path.

Expand

Flipper - any chance that your wishes were granted re invitro tests for Dementia and Parkinsons?

NEU Price at posting: $12.11 Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

First 86 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $13.79		Change 1.250(9.97%)		Mkt cap ! $1.729B

Open	High	Low	Value	Volume
$12.96	$14.00	$12.91	$12.90M	939.4K

Buyers (Bids)

No.	Vol.	Price($)
2	176	$13.77

Sellers (Offers)

Price($)	Vol.	No.
$13.79	712	4

View Market Depth

No.	Vol.	Price($)
7	253	13.820
3	716	13.810
2	416	13.800
5	1309	13.790
4	1316	13.780

Price($)	Vol.	No.
13.830	1	1
13.840	788	10
13.850	1423	4
13.860	1392	6
13.870	1291	4

Last trade - 14.29pm 26/06/2025 (20 minute delay)

NEU (ASX) Chart

NEU is materially undervalued, page-86

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

NEU is materially undervalued, page-86

Top Stories

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News